Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Hair loss can cause significant emotional and psychological distress.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

More research, better treatments, and public education are needed for dermatological conditions in people of African descent.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Chemical relaxers may cause scarring alopecia in black women.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Certain hairstyles in an urban South African township are linked to specific scalp disorders.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.